EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.889
https://www.valueinhealthjournal.com/article/S1098-3015(22)01090-7/fulltext
Title :
EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01090-7&doi=10.1016/j.jval.2022.04.889
First page :
Section Title :
Open access? :
No
Section Order :
10807